Biotechnology News

FDA Authorizes AI Sepsis Prediction, Detection Tool

April 5, 2024 - On April 3, 2024, the United States FDA granted Prenosis Inc. De Novo marketing authorization for Sepsis ImmunoScore. The tool is an artificial intelligence (AI) and machine learning (ML) software that can predict the risk of sepsis and aid in early diagnosis, allowing for prompt treatment. "FDA authorization of a sepsis diagnostic tool with...


Articles

FDA authorizes pre-exposure prophylaxis for COVID-19

by

Invivyd was granted an Emergency Use Authorization by the United States FDA for PEMGARDA, a pre-exposure prophylaxis (PrEP) treatment for COVID-19. The administration is authorizing the therapy for...

Companies Produce First Genetically Engineered Porcine Donors

by

On February 13, 2024, eGenesis, a United States-based biotechnology company, and PorMedTec, a Japanese porcine embryology organization, announced positive results of their collaboration, which produced...

University of Wisconsin Researchers 3D Print Functional Brain Tissue

by

On Friday, February 1, 2024, researchers at the University of Wisconsin–Madison (UW–Madison) revealed they had developed the first 3D-printed functional human brain tissue. Unlike previous...

American Red Cross Tackles National Blood Shortage with Technology

by

On January 7, 2024, the American Red Cross, the largest blood supplier in the nation, disclosed a critical national blood shortage. This announcement follows a 20-year low in blood donations, causing...

Quest, Universal DX Collaborate to Advance Colorectal Cancer Screening

by

On November 20, 2023, Universal DX (UDX), a biotechnology company, announced its collaboration with Quest Diagnostics, one of the two most significant lab services in the United States, to study,...

FDA Authorizes First Chlamydia, Gonorrhea At-Home Sample Test

by

On Wednesday, the United States Food and Drug Administration (FDA) authorized the Simple 2 Test manufactured by LetsGetChecked. The test is the first authorized chlamydia and gonorrhea diagnostic tool...

ctDNA Testing Reduces Time to Treatment for Lung Cancer Patients

by

A nonrandomized clinical trial published in JAMA Network Open revealed that circulating tumor DNA (ctDNA) before tissue diagnosis can reduce the time to treatment in patients with suspected advanced...

Washington University Scientists Developed Air Monitor to Detect COVID

by

Researchers and scientists at Washington University in St. Louis developed an air monitor to detect COVID-19 variants in the surrounding air. The researchers published a proof-of-concept study in...

Machine Learning Tool Analyzes Behavior-Associated Synaptic Plasticity

by

“When applied to in vivo images from transgenic mice expressing fluorescently labeled glutamate receptors, this restoration algorithm super-resolved synapses, enabling the tracking of...

Brain-Eating Amoeba Testing to Expand Beyond Florida Across the US

by

Jose Alexander, MD, a clinical microbiologist and director of microbiology, virology, and immunology for AdventHealth Orlando, and his team have expanded access to their brain-eating amoeba test beyond...

Liquid Biopsy Improves Colorectal Cancer Screening Rates in Veterans

by

A study published in Clinical Gastroenterology and Hepatology found that incorporating liquid biopsy screening for colorectal cancer improved screening rates among veterans between 50 and 75. The...

NEDA Takes Down AI Chatbot for Eating Disorder Helpline

by

In an abrupt turn of events, the National Eating Disorder Association (NEDA) will begin using an AI chatbot for its National Eating Disorder Helpline on June 1, 2023. This turn of events shocked...

Florida Reports Death Associated with Brain-Eating Amoeba Infection

by

On February 20, 2023, a man in Florida died from an infection with Naegleria fowleri, often called a brain-eating amoeba. The CDC reported that the disease was associated with an improper nasal rinse...

Researchers 3D Engineer Complex Skin Graft for Extensive Skin Injury

by

In an article published in Science Advances earlier this year, researchers from Columbia University detailed the process of developing and testing 3D-engineered complex skin grafts in the shape of...

Stem Cell Transplant Cures HIV in Third Patient, Alternative to ART

by

An article published in Nature on February 20, 2022, revealed that a third patient has been cleared of HIV cells, essentially curing the patient, after a stem cell transplant with HIV-resistant stem...

Orchestra BioMed Goes Public After $110 Million PE Fund Raise

by

Orchestra BioMed was introduced on the Nasdaq Global Market this month after completing its combination with the special purpose acquisition company Health Sciences Acquisitions Corporation 2. Gross...

Viatris Closes Acquisitions of Oyster Point Pharma and Famy Life Sciences

by

At the beginning of this month, global healthcare firm Viatris Inc announced the completion of its Oyster Point Pharma and Famy Life Sciences acquisitions. The two companies will be combined, and...

Nanorobot Antibodies to Treat Cancer

by

According to the American Cancer Society, cancer is one of the leading causes of death in the United States, second only to heart disease, and there are approximately 1.9 million new cancer cases and...

Only 14% of Cancers in the US Are Detected Through Screening

by

In a recent analysis by the NORC at the University of Chicago, researchers analyzed the efficacy of cancer screening tools by determining what percentage of cancers are detected through screening....